CNN – A victory for the morning-after pill
Aaron Carroll June 11, 2013
I blogged this morning about the Plan B reversal that occurred yesterday. I discussed the history of this fight, and what it means more thoroughly in a
I blogged this morning about the Plan B reversal that occurred yesterday. I discussed the history of this fight, and what it means more thoroughly in a
We’ve all heard about Oregon’s Medicaid experiment, but there was another one recently that deserves a bit of attention too: Wisconsin’s. Unlike Oregon, Wisconsin did
I thank Judith Viorst and her classic bedtime story for the words to express my feelings about the report of an RCT from Anne Kennedy
Given my repeated lambasting of the Obama administration for their seemingly anti-science view of Plan B, it’s only fitting that I also note their reversal:
Austin and I have a piece over at Bloomberg View: The U.S. spends $2.8 trillion a year on health care, about 18 percent of the
The FDA is moving forward to let some antibiotics get to market with only 200-400 people in the clinical trial. Minnesota Public Radio gave us
I have tried – hard – not to continue to talk about this issue. I think the “plight of the bros” is a distraction. It’s
Adrianna McIntyre and Josh Fangmeier just published a data- and chart-rich post on income and age characteristics of the individual market. It adds considerable detail
From “Limits Of Readmission Rates In Measuring Hospital Quality Suggest The Need For Added Metrics,” by Matthew Press et al.: Readmission rates in 2011 had
This post has two points. One is substantive. The other concerns tradeoffs between academic publications and blogging. (Apologies if title is lost on non-NBA-playoff fans.)
The 143-year-old tree is in Tochigi, Japan. More images here. @afrakt
Marty Gaynor held office hours on Twitter (@MartinSGaynor) this afternoon to address this question. Here’s a screenshot of his tweets. (Read from bottom up.) Here